Literature DB >> 2581648

Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve section.

M Fitzgerald, P D Wall, M Goedert, P C Emson.   

Abstract

The sciatic nerve was sectioned unilaterally in rats and nerve growth factor (NGF) applied locally to the nerve stump for the following 10-14 days using an indwelling osmotic pump. The aim of the experiment was to test whether NGF had any effect on the previously reported neurophysiological and neurochemical events that occur central to a peripheral nerve lesion. The method of application allowed the sciatic nerve on the other side to be used as a control. Primary afferent depolarization fell, as expected, to 13% of its control value after chronic nerve section but if NGF was administered it fell to only 43.5% of control. Chronic nerve section is also known to result in expansion of the receptive fields of deafferented dorsal horn cells. NGF treatment reduced the number of such large receptive fields by 50%. The normal depletion of fluoride resistant acid phosphatase from the cut nerve terminals in the dorsal horn did not occur following NGF treatment. Radioimmunoassay of substance P revealed that the 30% reduction in dorsal horn levels that follows chronic sciatic nerve section did not occur when NGF was applied and that the accompanying 60% decrease in dorsal root ganglion levels was changed to a 64% increase by NGF. The results show that chronic NGF treatment of a cut sciatic nerve does partially reverse the central changes that normally follow deafferentation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581648     DOI: 10.1016/0006-8993(85)90396-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

Review 1.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

2.  Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons.

Authors:  P G Murphy; L S Borthwick; R S Johnston; G Kuchel; P M Richardson
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

3.  Glycosylation alters steady-state inactivation of sodium channel Nav1.9/NaN in dorsal root ganglion neurons and is developmentally regulated.

Authors:  L Tyrrell; M Renganathan; S D Dib-Hajj; S G Waxman
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 4.  Changes in cytoskeletal protein synthesis following axon injury and during axon regeneration.

Authors:  M A Bisby; W Tetzlaff
Journal:  Mol Neurobiol       Date:  1992 Summer-Fall       Impact factor: 5.590

5.  Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor.

Authors:  Y O Taiwo; J D Levine; R M Burch; J E Woo; W C Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 6.  In search of lost presynaptic inhibition.

Authors:  Pablo Rudomin
Journal:  Exp Brain Res       Date:  2009-03-26       Impact factor: 1.972

7.  Nerve growth factor depletion reduces collateral sprouting of cutaneous mechanoreceptive and tooth-pulp axons in ferrets.

Authors:  B Doubleday; P P Robinson
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

8.  Schwann cell engraftment into injured peripheral nerve prevents changes in action potential properties.

Authors:  Kewei Yu; Jeffery D Kocsis
Journal:  J Neurophysiol       Date:  2005-08       Impact factor: 2.714

9.  NT-3 modulates NPY expression in primary sensory neurons following peripheral nerve injury.

Authors:  G D Sterne; R A Brown; C J Green; G Terenghi
Journal:  J Anat       Date:  1998-08       Impact factor: 2.610

10.  Expression of neuropeptides and neuropeptide mRNAs in spinal cord after axotomy in the rat, with special reference to motoneurons and galanin.

Authors:  X Zhang; V M Verge; Z Wiesenfeld-Hallin; F Piehl; T Hökfelt
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.